Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CKM - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KLC3 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
MARK4 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
ERCC2 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PPP1R13L - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
EXOC3L2 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
CD3EAP - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
BLOC1S3 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
ERCC1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
TRAPPC6A - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
NKPD1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PPP1R37 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on